BSE Live
Oct 31, 16:01Prev. Close
357.70
Open Price
350.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Cash Flow of Trident Texofab (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1.53 | 1.69 | 0.75 | 0.33 | 0.09 | |
| Net CashFlow From Operating Activities | -2.85 | -2.75 | -2.45 | 0.13 | 0.70 | |
| Net Cash Used In Investing Activities | -2.41 | -6.61 | -2.27 | -0.54 | -0.10 | |
| Net Cash Used From Financing Activities | 4.95 | 9.59 | 3.09 | 2.11 | -0.63 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.31 | 0.22 | -1.62 | 1.69 | -0.02 | |
| Cash And Cash Equivalents Begin of Year | 0.39 | 0.17 | 1.86 | 0.16 | 0.22 | |
| Cash And Cash Equivalents End Of Year | 0.08 | 0.39 | 0.23 | 1.86 | 0.19 |
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
26.08.2025
Trident Texofab Standalone June 2025 Net Sales at Rs 28.08 crore, up 9.2% Y-o-Y
19.06.2025
Trident Texofab Standalone March 2025 Net Sales at Rs 38.21 crore, up 26.63% Y-o-Y
04.02.2025
Trident Texofab Standalone December 2024 Net Sales at Rs 31.69 crore, up 37.72% Y-o-Y
21.10.2024
Trident Texofab Standalone September 2024 Net Sales at Rs 26.45 crore, up 13.99% Y-o-Y
05.04.2017
30.03.2017
29.03.2017
28.03.2017